| scholarly article | Q13442814 |
| P50 | author | Gerardo Chowell | Q30089970 |
| Cécile Viboud | Q30089971 | ||
| Lone Simonsen | Q37605549 | ||
| Mark A. Miller | Q90066983 | ||
| Santiago Echevarría-Zuno | Q114340154 | ||
| Víctor H Borja-Aburto | Q114340155 | ||
| P2093 | author name string | Cesar González-Bonilla | |
| Irma Fernández-Gárate | |||
| P2860 | cites work | Pandemic potential of a strain of influenza A (H1N1): early findings | Q24286924 |
| Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009) | Q24632365 | ||
| Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 | Q28260987 | ||
| Critically Ill patients with 2009 influenza A(H1N1) in Mexico | Q28261205 | ||
| Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China | Q28749090 | ||
| Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza | Q30227298 | ||
| Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis | Q30227428 | ||
| Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. | Q30227429 | ||
| Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. | Q30366558 | ||
| Severe respiratory disease concurrent with the circulation of H1N1 influenza. | Q30378512 | ||
| Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. | Q30379529 | ||
| Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. | Q30380173 | ||
| Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. | Q30380575 | ||
| Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. | Q30381264 | ||
| Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City | Q30381410 | ||
| Critical care services and 2009 H1N1 influenza in Australia and New Zealand. | Q30381497 | ||
| Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. | Q30382272 | ||
| Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. | Q30382490 | ||
| Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). | Q30382655 | ||
| Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. | Q30382712 | ||
| Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. | Q30384053 | ||
| Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. | Q30384722 | ||
| Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. | Q30387004 | ||
| Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus. | Q30387099 | ||
| Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women | Q30387165 | ||
| Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? | Q30388008 | ||
| Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
| Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. | Q30391675 | ||
| Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. | Q30392786 | ||
| No one is naive: the significance of heterologous T-cell immunity. | Q34136406 | ||
| Evidence of bias in estimates of influenza vaccine effectiveness in seniors | Q34478438 | ||
| A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database | Q39210737 | ||
| Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico | Q40385742 | ||
| 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. | Q43174219 | ||
| Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine | Q43858707 | ||
| Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine | Q45382232 | ||
| How Did the 2008–2009 Seasonal Influenza Vaccine Affect the Pandemic? | Q57106095 | ||
| Events temporarily associated with anti-influenza A (H1N1) vaccination in Mexico | Q82254200 | ||
| Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections | Q30393399 | ||
| Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study | Q30394200 | ||
| Severe pandemic (H1N1)v influenza A infection: report on the first deaths in Spain | Q30394861 | ||
| Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico | Q30394899 | ||
| French experience of 2009 A/H1N1v influenza in pregnant women | Q30395018 | ||
| Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study | Q30395522 | ||
| Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong | Q30396064 | ||
| Novel influenza A (H1N1) in patients with hematologic disease | Q30396282 | ||
| Clinical features of the 2009 swine-origin influenza A (H1N1) outbreak in Japan | Q30397744 | ||
| A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). | Q30398268 | ||
| Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China | Q30398438 | ||
| Comparison of patients hospitalized with pandemic 2009 influenza A (H1N1) virus infection during the first two pandemic waves in Wisconsin | Q30399095 | ||
| No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England | Q30399327 | ||
| Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain | Q30399902 | ||
| Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico | Q30403311 | ||
| Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. | Q30403558 | ||
| Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis | Q30404745 | ||
| Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico | Q30404888 | ||
| Epidemiology of influenza-like illness during Pandemic (H1N1) 2009, New South Wales, Australia. | Q30404928 | ||
| Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. | Q30405388 | ||
| Risk factors for death from pandemic (H1N1) 2009, southern Brazil. | Q30405404 | ||
| Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study | Q30405999 | ||
| Hospitalization of pregnant women with pandemic A(H1N1) 2009 influenza in Canada | Q30407115 | ||
| Immune responses to influenza virus infection | Q30407654 | ||
| Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza | Q30407838 | ||
| Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients | Q30410097 | ||
| Clinical characteristics and outcomes of diabetic patients who were hospitalised with 2009 pandemic influenza A H1N1 infection. | Q30410224 | ||
| Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010. | Q30414225 | ||
| Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity | Q30415149 | ||
| No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. | Q30415608 | ||
| Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico | Q30415719 | ||
| Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010 | Q30419774 | ||
| Improving the clinical diagnosis of influenza--a comparative analysis of new influenza A (H1N1) cases | Q33521204 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| P304 | page(s) | e41069 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico | |
| P478 | volume | 7 |
| Q30385942 | A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic |
| Q30353609 | Clinical care for severe influenza and other severe illness in resource-limited settings: the need for evidence and guidelines. |
| Q30354006 | Commentary: lessons learned from case fatality risk estimates of 2009 pandemic influenza. |
| Q30370215 | Comparison of severely ill patients with influenza A(H1N1)pdm09 infection during the pandemic and post-pandemic periods in Singapore. |
| Q33670505 | Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza |
| Q40462589 | Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus. |
| Q36166216 | Epidemiology and Surveillance of Influenza Viruses in Uganda between 2008 and 2014 |
| Q64067481 | Factors associated with fatal cases of acute respiratory infection (ARI) among hospitalized patients in Guatemala |
| Q26799330 | Hospitalization Fatality Risk of Influenza A(H1N1)pdm09: A Systematic Review and Meta-Analysis |
| Q34828228 | Influenza A virus infection of vascular endothelial cells induces GSK-3β-mediated β-catenin degradation in adherens junctions, with a resultant increase in membrane permeability |
| Q58051969 | Influenza Vaccine and Autoimmune Diseases |
| Q35192751 | Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. |
| Q92373747 | Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis |
| Q28357789 | Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis |
| Q30401871 | Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1. |
| Q30419774 | Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010 |
| Q30398670 | Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15. |
| Q45325856 | Screening differential miRNAs responsible for permeability increase in HUVECs infected with influenza A virus |
| Q45323600 | Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013. |
| Q47576940 | The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza |
| Q59361037 | The burden of influenza A and B in Mexico from the year 2010 to 2013: An observational, retrospective, database study, on records from the Directorate General of Epidemiology database |
Search more.